Total Funding
80
70
Total FundingPost-IPO Equity raised
Growth Score
-16 pts
Heat Score
-23 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
8855
Zura Bio is a clinical-stage, multi-asset biotechnology company.
- Verender Badial: Chief Financial Officer
- Tauhid Ali: COO & DirectorPast Role: Takeda, Vice President TAKcelerator
About the Company
Zura Bio is a clinical-stage, multi-asset biotechnology company dedicated to developing novel dual-pathway antibody medicines for the treatment of serious autoimmune and inflammatory disorders. The company’s approach—targeting two disease-driving mechanisms at once—is designed to offer potentially greater efficacy, safety, and dosing advantages
over single-target treatments.
